LEU

Centrus Energy

Q1 FY2026 earnings · 2026-05-12$0.63 consensus

Summary

What they do:

The only US-owned uranium enrichment company, operating a demonstration HALEU (high-assay low-enriched uranium) cascade in Piketon, Ohio, while running a legacy SWU trading and brokerage business that accounts for the vast majority of today's revenue.

Why they matter:

Advanced reactors — SMRs, HTGRs, molten salt designs — need HALEU fuel enriched to ~20% U-235, and Centrus is the sole licensed domestic producer. A $900M DOE award is funding a commercial-scale expansion, but the first new cascade is not expected online until 2029.

Recent performance:

FY2025 revenue $448.7M (+1.5% YoY), net income $77.8M. Guided 2026 revenue $425–475M. $3.8B backlog extending to 2040. Stock ~$200, market cap ~$3.9B.

Our Verdict

Play TypeSpeculative
Rel. ValueFair

Only domestic HALEU enricher with a DOE contract — nuclear fuel monopoly for SMRs, but pre-revenue on HALEU with massive dilution risk and a $2.7B market cap riding on technology that may take a decade to deploy at scale.

Structural trends

Nuclear renaissance narrativeenergy security legislationadvanced reactor development timelinesDOE funding commitmentsRussian enrichment sanctions

Structural

76

/ 100

Moat

7/10

Only US HALEU enricher with DOE contract and NRC license — regulatory monopoly for now, but Russia can re-enter and centrifuge tech is replicable long-term

AI Exp.

Stub

~5% AI

Play Type

Speculative

AI Growth

~0%

Rel. Value

32

FAIR

PriceLIVE

$193.11

+0.58%

Live via Yahoo Finance · refreshes every 5 min

Market Cap

$3.8B

P/E Ratio

49.5

P/S Ratio

8.5x

52W High

$464.25

52W Low

$60.52

52W Chg

219.1%

Beta

1.36

Supply Chain Dependencies

The Catch

The entire growth thesis depends on a technology ecosystem — advanced nuclear reactors — that is still pre-commercial. Centrus does not control when its customers will be ready to buy. The HALEU enrichment monopoly is real, but it protects a market that generates ~$100M/year in government contracts today, not the multi-billion-dollar fuel market that the stock price implies. If reactor developers hit their timelines, Centrus is a generational strategic asset. If they don't — and nuclear has a perfect track record of timeline slippage — Centrus is a $400M SWU brokerage trading at nearly 9x sales. The $900M DOE award funds the build, but it cannot manufacture customer demand.

If They Win

If the advanced reactor fleet deploys on schedule and HALEU demand scales to 10+ MT/year by the mid-2030s, Centrus becomes the fuel supply backbone of the next-generation nuclear industry. With proven centrifuge technology, first-mover commercial capacity, and years of production experience by that point, Centrus would hold a chokepoint position similar to TSMC in advanced chips — the entity everyone depends on, with no near-term alternative. Revenue could reach $1–2B with enrichment-grade margins. The strategic premium — energy security, defense applications, allied nation fuel supply — would make this one of the most irreplaceable companies in the energy infrastructure stack. The stock in that scenario is a multi-bagger from current levels.

Not financial advice. All scores generated via AI algorithms using public data.